CN107261105A - Treat the Chinese patent drug of cardiovascular and cerebrovascular disease - Google Patents
Treat the Chinese patent drug of cardiovascular and cerebrovascular disease Download PDFInfo
- Publication number
- CN107261105A CN107261105A CN201710495590.3A CN201710495590A CN107261105A CN 107261105 A CN107261105 A CN 107261105A CN 201710495590 A CN201710495590 A CN 201710495590A CN 107261105 A CN107261105 A CN 107261105A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese patent
- extract
- patent drug
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to technical field of traditional Chinese medicines, more particularly to a kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, it is made up of the raw material of following parts by weight：30 45 parts of active peptides, 30 40 parts of Fructus Alpinae Oxyphyllae extract, 25 38 parts of kudzu root extract, 21 32 parts of safflower, 13 25 parts of taurine, 15 28 parts of rhodiola root, 10 22 parts of lycopodium powder, 6 15 parts of blueberry extract; the Chinese patent drug can bidirectional modulation blood pressure, prevent apoplexy；Brain cell is repaired, strengthens brain microcirculation, prevents brain dementia；Improve internal pH-value.Treatment angiocardiopathy can treat both principal and secondary aspect of disease, with good effect.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, more particularly to a kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease.
Background technology
Cardiovascular and cerebrovascular disease, also known as circulation system disease, are a series of diseases for being related to the circulatory system, and the circulatory system refers to
Hemophoric organ and tissue in human body, mainly including heart, blood vessel (artery, vein, capilary), can be subdivided into
It is acute and chronic, it is typically all relevant with artery sclerosis.
Improved now with living standard, the change of dietary structure, intake fat, the amount of cholesterol are incrementally increased,
The crowd for suffering from angiocardiopathy is also increasing, and cardiovascular and cerebrovascular disease has occupied the prostatitis of China's Disease causation, as people
One big threat of class health.Cardiovascular and cerebrovascular disease species is various, common are coronary heart disease, hypertension, angina cordis, heart disease infarct
Deng.Clinical treatment, western medical treatment mainly has the medicines, western medicine instant effect such as expansion blood vessel, thrombolysis, decompression, it is adaptable to
Rescue treatment, because the side effect of Western medicine is larger, different degrees of injury can be brought to blood vessel and human organ by being used for a long time.
Traditional Chinese medicine prevention cardiovascular disease focuses on conditioning, and comprehensive rehabilitation to physical function is highly profitable, and side effect is smaller.
The content of the invention
It is an object of the invention to for problem above, and a kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease is provided, this
The drug effect of Chinese patent drug is fast, effect is good.
What the present invention was realized in：A kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, by the raw material of following parts by weight
Composition：30-45 parts of active peptides, 30-40 parts of Fructus Alpinae Oxyphyllae extract, 25-38 parts of kudzu root extract, 21-32 parts of safflower, taurine
13-25 parts, 15-28 parts of rhodiola root, 10-22 parts of lycopodium powder, 6-15 parts of blueberry extract.
The Chinese patent drug of above-mentioned treatment cardiovascular and cerebrovascular disease, is made up of the raw material of following parts by weight：Active peptides 34-42
Part, 33-37 parts of Fructus Alpinae Oxyphyllae extract, 28-35 parts of kudzu root extract, 23-30 parts of safflower, 16-22 parts of taurine, rhodiola root 18-
25 parts, 12-20 parts of lycopodium powder, 8-13 parts of blueberry extract.
The Chinese patent drug of above-mentioned treatment cardiovascular and cerebrovascular disease, is made up of the raw material of following parts by weight：38 parts of active peptides,
35 parts of Fructus Alpinae Oxyphyllae extract, 32 parts of kudzu root extract, 26 parts of safflower, 19 parts of taurine, 21 parts of rhodiola root, 16 parts of lycopodium powder, indigo plant
10 parts of certain kind of berries extract.
The Chinese patent drug of above-mentioned treatment cardiovascular and cerebrovascular disease, the active peptides are extracted from cattle and sheep marrow.
The pharmacological effect of each bulk drug is needed for this Chinese patent drug：
Active peptides：The division of cell can be promoted, the metabolism of cell is adjusted, it is ensured that the quantity of intracellular protein synthesis,
Quality and speed are in normal condition, improve the reasonable utilization rate of protein.And then control human body growth and development, aging with
Disease.
Fructus Alpinae Oxyphyllae extract：Meridian distribution of property and flavor, temperature is pungent, returns kidney, the spleen channel, for malaria diarrhea, crymodynia in abdomen, many salivas of mouth,
Enuresis with renal asthenia, frequent urination, gonorrhoea of passing out semen.
Kudzu root extract：Blood vessel can be expanded, improves blood circulation；Myocardial oxygen consumption is reduced, suppresses cancer cell；Increase coronary artery
Flow, adjusts blood microcirculation；Treat the sudden deafness of each age level；Reduce cardiovascular and cerebrovascular disease dangerous.
Safflower：Invigorate blood circulation, blood stasis removing analgesic, contribute to controlling through closing, dysmenorrhoea, lochia, chest impediment and cardialgia, stasis of blood,
Chest side of body shouting pain, traumatic injury, sore swell and ache curative curative effect.Have promoting blood circulation and removing blood stasis, effect of dissipate wet effect going to swell.《The correction of the errors of medical works》：Promoting blood circulation,
Promoting qi circulation and relieving pain, cures mainly blood stasis in the heart, hematogenous blockage, pectoralgia, and with the passing of time headache is not cured, stabbing opthalmalgia and have and determine the diseases such as place；Promoting blood circulation is logical
Key, blood-activating and qi-promoting, eliminating blood stasis and smoothing collaterals, numbness relieving and pain relieving cures mainly the shoulder pain caused by qi and blood numbness resistance channels and collaterals, brachialgia, pain in the back, skelagia, or week
Body pain, does not recover for a long time.
Taurine：Taurine can suppress platelet aggregation in the circulatory system, reduce blood fat, keep human normal blood pressure and
Prevent artery sclerosis;There is protective effect to cardiac muscle cell, can anti-arrhythmia;There is special treatment to reduction blood cholesterol level
Effect, can treat heart failure.Cardiac contractile force can be strengthened, myocardial hypoxia tolerance effect is improved.Taurine can be safeguarded many thin
Born of the same parents, particularly haemocyte antioxidation activity, make tissue from the damage of oxidation base and free radical.
Rhodiola root：There are tonifying Qi clearing lung-heat, intelligence development nourishing heart, controlling of bleeding with astringents, eliminating stasis to subdue swelling.Cure mainly deficiency of vital energy and physically weak, after being ill
Chilly, shortness of breath and fatigue, cough with lung heat, spitting of blood, leukorrhea diarrhoea, traumatic injury etc..《Sheng Nong's herbal classic》：Rhodiola root：Make light of one's life by commiting suicide QI invigorating,
Not old macrobiosis, nontoxic many clothes, long term usage is not hurted sb.'s feelings.Energy kidney tonifying, qi-regulating blood-nourishing is cured mainly weak, uncomfortable in chest etc. all over the body；Also stop with promoting blood circulation
It is blood, removing heat from the lung to relieve cough, antipyretic, and effect under stop-band.
Lycopodium powder：It is warm-natured sweet.With yin-nourishing, relieve dizziness, high fever, infantile convulsions, epilepsy, etc., moistening lung, laxation the effects such as.Contained unrighted acid and big
Mineral matter such as calcium, iron, phosphorus etc. are measured, blood vessel elasticity can be strengthened, the normal condition of capillary is safeguarded, blood fat is reduced, prevents the heart
Vascular diseases；Pine nut Glutamic Acid content is up to 16.3%, and glutamic acid has good brain strengthening function, can strengthen memory.
Blueberry extract：Increase the pliability of capillary, can be with pure promotion vascular dilation and retractility, anti-hemostatic tube
Rupture.Antioxidant is provided, can eliminate makes the free radical of vascular sclerosis, prevention of arterial hardening.Cranial nerve aging, enhancing can be prevented
Cardiac function.
The present invention has the following advantages that：Above-mentioned all medicine compatibilities, can be anti-oxidant, eliminates free radical, being capable of bidirectional modulation blood
Pressure, prevents apoplexy；Brain cell is repaired, strengthens brain microcirculation, prevents brain dementia；Improve internal pH-value.Treat heart and brain
Vascular diseases can treat both principal and secondary aspect of disease, with good effect.The Chinese patent drug instant effect of the present invention, Small side effects.
Embodiment
With reference to specific embodiment, the invention will be further described.
Embodiment 1：A kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, is made up of the raw material of following weight：Active peptides 30
Gram, 30 grams of Fructus Alpinae Oxyphyllae extract, 25 grams of kudzu root extract, 21 grams of safflower, 13 grams of taurine, 15 grams of rhodiola root, 10 grams of lycopodium powder,
6 grams of blueberry extract.The Chinese patent drug that the present embodiment is made mainly is applicable crowd：Cardiovascular and cerebrovascular blood supply insufficiency, cerebral angiospasm,
Sequel resulted from cardio-cerebral blood-vessel diseases, long-term overstrain one's nerves cause insomnia, forgetful, failure of memory sub-health population.Instructions of taking is：
According to different situations such as patient's physical strength, state of an illness weight, age sizes, orally, 3 times a day, each taking 3-6, after the meal
Half an hour takes, and capsule form is made in the present embodiment Chinese patent drug.
Embodiment 2：A kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, is made up of the raw material of following weight：Active peptides 45
Gram, 40 grams of Fructus Alpinae Oxyphyllae extract, 38 grams of kudzu root extract, 32 grams of safflower, 25 grams of taurine, 28 grams of rhodiola root, 22 grams of lycopodium powder,
15 grams of blueberry extract.The Chinese patent drug that the present embodiment is made mainly is applicable crowd：Cardiovascular and cerebrovascular blood supply insufficiency, cerebrovascular convulsion
Contraction, sequel resulted from cardio-cerebral blood-vessel diseases, long-term overstrain one's nerves cause insomnia, forgetful, failure of memory sub-health population.Instructions of taking
For：According to different situations such as patient's physical strength, state of an illness weight, age sizes, orally, 3 times a day, each taking 3-6,
Half an hour takes after the meal.
Embodiment 3：A kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, is made up of the raw material of following weight：Active peptides 33
Gram, 32 grams of Fructus Alpinae Oxyphyllae extract, 36 grams of kudzu root extract, 22 grams of safflower, 23 grams of taurine, 17 grams of rhodiola root, 11 grams of lycopodium powder,
14 grams of blueberry extract.The Chinese patent drug that the present embodiment is made mainly is applicable crowd：Cardiovascular and cerebrovascular blood supply insufficiency, cerebrovascular convulsion
Contraction, sequel resulted from cardio-cerebral blood-vessel diseases, long-term overstrain one's nerves cause insomnia, forgetful, failure of memory sub-health population.Instructions of taking
For：According to different situations such as patient's physical strength, state of an illness weight, age sizes, orally, 3 times a day, each taking 3-6,
Half an hour takes after the meal.
Embodiment 4：A kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, is made up of the raw material of following weight：Active peptides 34
Gram, 33 grams of Fructus Alpinae Oxyphyllae extract, 28 grams of kudzu root extract, 23 grams of safflower, 16 grams of taurine, 18 grams of rhodiola root, 12 grams of lycopodium powder,
8 grams of blueberry extract.The Chinese patent drug that the present embodiment is made mainly is applicable crowd：Cardiovascular and cerebrovascular blood supply insufficiency, cerebral angiospasm,
Sequel resulted from cardio-cerebral blood-vessel diseases, long-term overstrain one's nerves cause insomnia, forgetful, failure of memory sub-health population.Instructions of taking is：
According to different situations such as patient's physical strength, state of an illness weight, age sizes, orally, 3 times a day, each taking 3-6, after the meal
Half an hour takes, and capsule form is made in the present embodiment Chinese patent drug.
Embodiment 5：A kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, is made up of the raw material of following weight：Active peptides 42
Gram, 37 grams of Fructus Alpinae Oxyphyllae extract, 35 grams of kudzu root extract, 30 grams of safflower, 22 grams of taurine, 25 grams of rhodiola root, 20 grams of lycopodium powder,
13 grams of blueberry extract.The Chinese patent drug that the present embodiment is made mainly is applicable crowd：Cardiovascular and cerebrovascular blood supply insufficiency, cerebrovascular convulsion
Contraction, sequel resulted from cardio-cerebral blood-vessel diseases, long-term overstrain one's nerves cause insomnia, forgetful, failure of memory sub-health population.Instructions of taking
For：According to different situations such as patient's physical strength, state of an illness weight, age sizes, orally, 3 times a day, each taking 3-6,
Half an hour takes after the meal, and capsule form is made in the present embodiment Chinese patent drug.
Embodiment 6：A kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, is made up of the raw material of following weight：Active peptides 37
Gram, 36 grams of Fructus Alpinae Oxyphyllae extract, 33 grams of kudzu root extract, 24 grams of safflower, 20 grams of taurine, 22 grams of rhodiola root, 18 grams of lycopodium powder,
10 grams of blueberry extract.The Chinese patent drug that the present embodiment is made mainly is applicable crowd：Cardiovascular and cerebrovascular blood supply insufficiency, cerebrovascular convulsion
Contraction, sequel resulted from cardio-cerebral blood-vessel diseases, long-term overstrain one's nerves cause insomnia, forgetful, failure of memory sub-health population.Instructions of taking
For：According to different situations such as patient's physical strength, state of an illness weight, age sizes, orally, 3 times a day, each taking 3-6,
Half an hour takes after the meal, and capsule form is made in the present embodiment Chinese patent drug.
Embodiment 7：A kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, is made up of the raw material of following weight：Active peptides 38
Gram, 35 grams of Fructus Alpinae Oxyphyllae extract, 32 grams of kudzu root extract, 26 grams of safflower, 19 grams of taurine, 21 grams of rhodiola root, 16 grams of lycopodium powder,
10 grams of blueberry extract.The Chinese patent drug that the present embodiment is made mainly is applicable crowd：Cardiovascular and cerebrovascular blood supply insufficiency, cerebrovascular convulsion
Contraction, sequel resulted from cardio-cerebral blood-vessel diseases, long-term overstrain one's nerves cause insomnia, forgetful, failure of memory sub-health population.Instructions of taking
For：According to different situations such as patient's physical strength, state of an illness weight, age sizes, orally, 3 times a day, each taking 3-6,
Half an hour takes after the meal, and capsule form is made in the present embodiment Chinese patent drug.
Marrow polypeptide has softening blood vessel, dredges capillary, makes blood vessel high resilience, improves the effect of myocardial viability,
Combined with Chinese medical extract, into blood after can be in rapid lysed blood the fat such as cholesterol, triglycerides, phosphatide, aliphatic acid
Class, and these harmful substances can be prevented to be excreted rapidly from stopping in blood.The root of kudzu vine, fructus alpiniae oxyphyllae, benefiting qi and nourishing blood, brain tonic
Intelligence development, can remove the harmful free radical of internal body portion.Nutrition brain tissue, protection brain cell, improvement brain microcirculation, are to adjust
Manage asthenic syndrome（There is numbness when headache, dizzy, weak, insomnia, dreaminess, memory loss, absent minded, four limbs）
And the symptom such as hypertension, high fat of blood, hyperglycaemia, cerebral arteriovenous malformation；Safflower, taurine, can enhancing myocardial contractive power promoting blood circulation and removing blood stasis,
Myocardial oxygen consumption is reduced, the symptom such as alleviates myocardial ischemia, uncomfortable in chest, shortness of breath caused by miocardial infarction, feel suffocated, and heart and brain blood can be promoted
The recovery of pipe sequelae and senile dementia；Rhodiola root, lycopodium powder can strengthen blood vessel elasticity, safeguard the normal shape of capillary
State, reduces blood fat, and pine nut Glutamic Acid content is up to 16.3%, and glutamic acid has good brain strengthening function, can strengthen memory；It is blue
Certain kind of berries extract can increase the pliability of capillary, can prevent angiorrhoxis with pure promotion vascular dilation and retractility.Carry
For antioxidant, can eliminate makes the free radical of vascular sclerosis, prevention of arterial hardening.Cranial nerve aging, enhancing heart work(can be prevented
Energy.
Using the obtained Chinese patent drug of above-described embodiment formula, clinical test is as follows：
Choose 200 cardiovascular patients and clinical test is carried out to the treatment curative effect of medicine of the present invention.Wherein, male 100
Example, women 100, age 35-65 Sui, course of disease 2-15.
Treatment method：
On the basis of original treatment, the former medicine taken is disabled, this medicine is taken, is within 10 days a course for the treatment of, continuous three courses for the treatment of.
Curative effect determinate standard：
Cure：Chest pain, cardio palmus shape disappear substantially, and electrocardiogram shows that ischemic state is returned to normal；
Effectively：Chest pain, cardio palmus shape mitigate or attack times are reduced, and electrocardiogram shows that myocardial ischemia improves：
It is invalid：Chest pain, cardio palmus shape are not improved, and electrocardiogram shows that ischemic state does not take a favorable turn to be invalid.
Experimental result：
Medicine of the present invention is taken after 30 days, 167 people are cured, cure rate 84%, 189 people are effective, account for 95%, 197 people have
Effect, accounts for 99%, 3 people are invalid, account for 1%.Probability without recurrence within 5 years after healing.It can be seen that, medicine of the invention is to heart and brain blood
Pipe disease has good therapeutic action.And the raw materials used medicine of the present invention is Chinese medicine, is had no toxic side effect, will not be to human body
Produce any harm.
Using the obtained Chinese patent drug of above-described embodiment formula, specific clinical case is as follows：
Case 1：Poplar, female, 55 years old, because shortness of breath uncomfortable in chest is to hospital on April 16th, 2012, body was looked into：Blood pressure 150/
100mmHg, every point of heart rate 86 times, chest distress is especially even more serious with morning, and chest secret anguish is more than 2 years, and eye, stomach are lost in dizziness
It is vexed swollen, defecate partially dry, red tongue body, tongue are thin white.Electrocardiogram shows, coronary insufficiency.It is diagnosed as coronary sclerosis.Give
Chinese patent medicine preparation of the present invention, 3 times a day, 3 every time, symptom mitigation uncomfortable in chest after treatment 10 days, and after medication 40 days, electrocardiogram is just
Often, blood pressure 130/80mmHg, symptom disappears, simply even to have shortness of breath symptom, two course for the treatment of rehabilitations of after treatment.
Case 2：Cao, man is 46 years old, to hospital on May 23rd, 2013 with hypertension, high fat of blood 7 years, main
Tell：Shortness of breath, pectoralgia, vexed, paroxysmal angina pectoris, expiratory dyspnea are felt the year before, by Electrocardioscopy, myocardial ischemia, hat
The display hardening of heart angiography, in hospitalize 1 year, does not improve again and again, to Chinese patent medicine preparation of the present invention, daily 4
Secondary, after 3 every time, 60 days, the state of an illness is clearly better, and symptom is substantially eliminated, three course for the treatment of rehabilitations of after treatment.
Case 3：Often certain, man, 62 years old, happened suddenly in October, 2010 pit of the stomach pain, carrys out examination in hospital, finds cardiovascula arteriosclerosis,
Luminal stenosis, electrocardiogram shows cardiac insufficiency, heart glue pain, palpitaition symptom often occurs, out of spirits, weak all over, has a meal
Have no appetite, sleep also not fragrant.To Chinese patent medicine preparation of the present invention, 3 times a day, symptom mitigation after 4 every time, 10 days, continues medication
Symptom disappears substantially after 20 days, normal ECG, after one course for the treatment of of after treatment, and symptom is completely without energy normal work.
Claims (4)
1. a kind of Chinese patent drug for treating cardiovascular and cerebrovascular disease, it is characterised in that：It is made up of the raw material of following parts by weight：Activity is more
It is 30-45 parts of peptide, 30-40 parts of Fructus Alpinae Oxyphyllae extract, 25-38 parts of kudzu root extract, 21-32 parts of safflower, 13-25 parts of taurine, red
15-28 parts of red-spotted stonecrop, 10-22 parts of lycopodium powder, 6-15 parts of blueberry extract.
2. the Chinese patent drug for the treatment of cardiovascular and cerebrovascular disease according to claim 1, it is characterised in that：By following parts by weight
Raw material is constituted：34-42 parts of active peptides, 33-37 parts of Fructus Alpinae Oxyphyllae extract, 28-35 parts of kudzu root extract, 23-30 parts of safflower, ox
16-22 parts of sulfonic acid, 18-25 parts of rhodiola root, 12-20 parts of lycopodium powder, 8-13 parts of blueberry extract.
3. the Chinese patent drug for the treatment of cardiovascular and cerebrovascular disease according to claim 1, it is characterised in that：By following parts by weight
Raw material is constituted：It is 38 parts of active peptides, 35 parts of Fructus Alpinae Oxyphyllae extract, 32 parts of kudzu root extract, 26 parts of safflower, 19 parts of taurine, red
21 parts of red-spotted stonecrop, 16 parts of lycopodium powder, 10 parts of blueberry extract.
4. the Chinese patent drug for the treatment of cardiovascular and cerebrovascular disease according to claim 1, it is characterised in that：The active peptides are from ox
Extracted in sheep marrow.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710495590.3A CN107261105A (en) | 2017-06-26 | 2017-06-26 | Treat the Chinese patent drug of cardiovascular and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710495590.3A CN107261105A (en) | 2017-06-26 | 2017-06-26 | Treat the Chinese patent drug of cardiovascular and cerebrovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107261105A true CN107261105A (en) | 2017-10-20 |
Family
ID=60069531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710495590.3A Pending CN107261105A (en) | 2017-06-26 | 2017-06-26 | Treat the Chinese patent drug of cardiovascular and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107261105A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101040988A (en) * | 2007-04-19 | 2007-09-26 | 赵德润 | Chinese prepared medicine compound for treating and preventing gynecologic endocrine disorders |
| CN101062027A (en) * | 2006-04-29 | 2007-10-31 | 黄振华 | Taurine and medical combination for treating cardiovascular and cerebrovascular diseases |
| CN101618131A (en) * | 2008-07-01 | 2010-01-06 | 北京中科仁和科技有限公司 | Chinese medicinal compound preparation for treating coronary heart disease and angina |
| CN102526581A (en) * | 2012-02-27 | 2012-07-04 | 刘小明 | Chinese medicinal composition for treating hypertension diseases |
| CN103041264A (en) * | 2012-12-31 | 2013-04-17 | 青岛华仁信息技术开发有限公司 | Kudzuvine root brain-boosting and intelligence-boosting oral solution with function of preventing vascular dementia and preparation method thereof |
| CN104855965A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food for patients with atherosclerosis |
| CN105288410A (en) * | 2015-11-28 | 2016-02-03 | 青岛麦瑞特医药技术有限公司 | Traditional Chinese medicine composition for treating diabetic nephropathy and application of traditional Chinese medicine composition |
-
2017
- 2017-06-26 CN CN201710495590.3A patent/CN107261105A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062027A (en) * | 2006-04-29 | 2007-10-31 | 黄振华 | Taurine and medical combination for treating cardiovascular and cerebrovascular diseases |
| CN101040988A (en) * | 2007-04-19 | 2007-09-26 | 赵德润 | Chinese prepared medicine compound for treating and preventing gynecologic endocrine disorders |
| CN101618131A (en) * | 2008-07-01 | 2010-01-06 | 北京中科仁和科技有限公司 | Chinese medicinal compound preparation for treating coronary heart disease and angina |
| CN102526581A (en) * | 2012-02-27 | 2012-07-04 | 刘小明 | Chinese medicinal composition for treating hypertension diseases |
| CN103041264A (en) * | 2012-12-31 | 2013-04-17 | 青岛华仁信息技术开发有限公司 | Kudzuvine root brain-boosting and intelligence-boosting oral solution with function of preventing vascular dementia and preparation method thereof |
| CN104855965A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food for patients with atherosclerosis |
| CN105288410A (en) * | 2015-11-28 | 2016-02-03 | 青岛麦瑞特医药技术有限公司 | Traditional Chinese medicine composition for treating diabetic nephropathy and application of traditional Chinese medicine composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101254272B (en) | Medicament for promoting coronary circulation and embolism resistance | |
| CN102018928B (en) | Method for preparing traditional Chinese medicine for treating hypothyroidism | |
| CN101537060B (en) | Medicine for treating AIDS | |
| CN103877486B (en) | For medicine and its preparation method of quantity of leucocyte after short lifting chemotherapy | |
| CN107261105A (en) | Treat the Chinese patent drug of cardiovascular and cerebrovascular disease | |
| CN108653588A (en) | External application traditional Chinese medicine for treating orthopedic diseases | |
| CN110604779A (en) | Traditional Chinese medicine formula for treating bone fracture | |
| CN108114118A (en) | A kind of acupoint plaster for treating antimigraine | |
| CN109806351A (en) | Neck-shoulder pain, lumbago and leg pain temperature, which is applied, to be dissipated | |
| CN104225488B (en) | Treat protrusion of lumber intervertebral disc and the medicine of osteoproliferation | |
| CN103110843A (en) | Traditional Chinese medicine composition for treating hemorrhagic stroke | |
| CN102008072B (en) | Blood pressure lowering edible wild herb food therapy composition | |
| CN107224497A (en) | One kind cures prolapse of rectum lavipeditum prescription | |
| CN106389663A (en) | Radix codonopsis containing acid discharging tea for treating gout | |
| CN105055864A (en) | Traditional Chinese medicine preparation for treating aplastic anemia | |
| CN106563054A (en) | A yang-invigorating medicine | |
| CN113144056A (en) | A Chinese medicinal composition for improving intelligence | |
| CN113509516A (en) | Traditional Chinese medicine composition for treating deafness | |
| CN108704062A (en) | A kind of Chinese medicine composition and preparation method thereof for treating coronary heart disease | |
| CN111729008A (en) | Traditional Chinese medicine composition for treating anemia | |
| CN103751397B (en) | A kind of Chinese medicine composition for the treatment of pressure ulcer | |
| CN104127825B (en) | Traditional Chinese medicine composition for treating spontaneous perspiration and night sweat after operation | |
| CN111759946A (en) | Traditional Chinese medicine composition for treating hernia | |
| CN108578650A (en) | A kind of navel paster for treating pain in the back | |
| CN107296848A (en) | A kind of Chinese medicine composition and preparation method for treating qi stagnation and blood stasis type phrenoblabia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171020 |
|
| RJ01 | Rejection of invention patent application after publication |